Evan David Seigerman, BMO, joins ‘Fast Money’ to talk what Trump appointments mean for the biotech and pharma sectors.
Source link
Trending
- Russia Gazprom says will halt gas supplies to Moldova starting Jan. 1
- At least 28 dead in fiery aircraft crash in South Korea, Yonhap reports
- Winning ticket for $1.22 billion lottery jackpot sold in California, Mega Millions says
- Elon Musk backs AfD party in German newspaper opinion piece
- Here’s what’s in a longevity doctor’s colorful, nutrient-dense salad
- Trump says H-1B visa program is ‘great’ amid MAGA feud over tech workers
- Mike Brown’s final days with the Kings: Disastrous play, tension with a star and an awkward firing
- Russini’s what I’m hearing: Vikings want Darnold back in 2025, Watson’s new deal, Brady’s big role
BMO expects Trump to pick a more conventional FDA commissioner after RFK Jr.'s nomination
